Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
APO-FLUOXETINE APOTEX INC Anticipated shortage 20MG New Report 2024-12-11 245462
APO-FLUOXETINE APOTEX INC Anticipated shortage 20MG New Report 2024-12-11 245459
APO-FLUOXETINE APOTEX INC Anticipated shortage 10MG New Report 2024-12-11 245456
BEYFORTUS SANOFI PASTEUR LIMITED Anticipated shortage 100MG Updated Report 2024-12-11 245452
AVENTYL AA PHARMA INC Actual shortage 10MG Updated Report 2024-12-11 245448
MINOCYCLINE AA PHARMA INC Actual shortage 50MG New Report 2024-12-11 245445
ELAVIL AA PHARMA INC Actual shortage 50MG New Report 2024-12-11 245442
METHOPRAZINE AA PHARMA INC Actual shortage 25MG Updated Report 2024-12-11 242915
ENALAPRIL MALEATE/HCTZ AA PHARMA INC Resolved 25MG 10MG Updated Report 2024-12-11 242184
MEFENAMIC AA PHARMA INC Resolved 250MG Updated Report 2024-12-11 240624
5% DEXTROSE INJECTION, USP BAXTER CORPORATION Actual shortage 5G Updated Report 2024-12-11 234262
0.9% SODIUM CHLORIDE INJECTION, USP BAXTER CORPORATION Actual shortage 900MG Updated Report 2024-12-11 234265
DOCUSATE SODIUM PRO DOC LIMITEE Actual shortage 100MG Updated Report 2024-12-11 241984
INDOCYANINE GREEN FOR INJECTION, USP DIAGNOSTIC GREEN LIMITED Actual shortage 25MG Updated Report 2024-12-11 234081
LMD 10% IN 0.9% SODIUM CHLORIDE PFIZER CANADA ULC Actual shortage 0.9% 10% Updated Report 2024-12-11 239954
ORILISSA ABBVIE CORPORATION Anticipated shortage 200MG Updated Report 2024-12-11 245420
WELLBUTRIN XL BAUSCH HEALTH, CANADA INC. Actual shortage 150MG Updated Report 2024-12-11 244139
RETIN-A BAUSCH HEALTH, CANADA INC. Actual shortage 0.025% Updated Report 2024-12-11 244980
RETROVIR (AZT) VIIV HEALTHCARE ULC Resolved 50MG Updated Report 2024-12-11 244220
M-MONTELUKAST MANTRA PHARMA INC Actual shortage 10MG New Report 2024-12-11 245411
M-LATANOPROST-TIMOLOL MANTRA PHARMA INC Actual shortage 5MG 50MCG New Report 2024-12-11 245408
M-LATANOPROST MANTRA PHARMA INC Actual shortage 50MCG New Report 2024-12-11 245405
M-LANSOPRAZOLE MANTRA PHARMA INC Actual shortage 30MG New Report 2024-12-11 245402
M-LANSOPRAZOLE MANTRA PHARMA INC Actual shortage 15MG New Report 2024-12-11 245399
M-BETAHISTINE MANTRA PHARMA INC Actual shortage 24MG New Report 2024-12-11 245396
M-BETAHISTINE MANTRA PHARMA INC Actual shortage 16MG New Report 2024-12-11 245393
M-BETAHISTINE MANTRA PHARMA INC Actual shortage 8MG New Report 2024-12-11 245390
M-AZITHROMYCIN MANTRA PHARMA INC Actual shortage 250MG New Report 2024-12-11 245387
M-AZITHROMYCIN MANTRA PHARMA INC Actual shortage 250MG New Report 2024-12-11 245384
M-LEVETIRACETAM MANTRA PHARMA INC Actual shortage 500MG New Report 2024-12-11 225527
M-LEVETIRACETAM MANTRA PHARMA INC Actual shortage 750MG New Report 2024-12-11 225536
M-PRAVASTATIN MANTRA PHARMA INC Actual shortage 20MG Updated Report 2024-12-11 225548
M-PRAVASTATIN MANTRA PHARMA INC Actual shortage 40MG Updated Report 2024-12-11 225556
M-SOLIFENACIN SUCCINATE MANTRA PHARMA INC Actual shortage 5MG New Report 2024-12-11 225565
M-SOLIFENACIN SUCCINATE MANTRA PHARMA INC Actual shortage 10MG New Report 2024-12-11 225571
M-QUETIAPINE FUMARATE XR MANTRA PHARMA INC Actual shortage 150MG New Report 2024-12-11 233180
M-QUETIAPINE FUMARATE XR MANTRA PHARMA INC Actual shortage 200MG New Report 2024-12-11 233183
M-QUETIAPINE FUMARATE XR MANTRA PHARMA INC Actual shortage 300MG New Report 2024-12-11 233186
M-QUETIAPINE FUMARATE XR MANTRA PHARMA INC Actual shortage 400MG New Report 2024-12-11 233189
ORILISSA ABBVIE CORPORATION Anticipated shortage 150MG Updated Report 2024-12-11 245357
PMS-CHLORHEXIDINE WITHOUT ALCOHOL PHARMASCIENCE INC Actual shortage 0.12% Updated Report 2024-12-11 211878
RIZATRIPTAN SANIS HEALTH INC Actual shortage 10MG Updated Report 2024-12-11 240737
MOXIFLOXACIN SANIS HEALTH INC Actual shortage 400MG Updated Report 2024-12-11 228981
LOSARTAN/HCTZ SANIS HEALTH INC Actual shortage 25MG 100MG Updated Report 2024-12-11 235045
CANDESARTAN/HCTZ SANIS HEALTH INC Actual shortage 12.5MG 16MG Updated Report 2024-12-11 240722
TOBRAMYCIN FOR INJECTION FRESENIUS KABI CANADA LTD Actual shortage 1.2G Updated Report 2024-12-11 245141
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Resolved 1.5MG Updated Report 2024-12-11 230768
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Resolved 4.5MG Updated Report 2024-12-11 234493
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Resolved 1.5MG Updated Report 2024-12-11 235071
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Resolved 6MG Updated Report 2024-12-11 235570

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Discontinued 1.5MG Updated Report 2024-12-11 245288
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Discontinued 6MG Updated Report 2024-12-11 245291
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES SANDOZ CANADA INCORPORATED Discontinued 240MG Updated Report 2024-12-11 245230
SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES SANDOZ CANADA INCORPORATED Discontinued 120MG Updated Report 2024-12-11 245267
SANDOZ FINASTERIDE SANDOZ CANADA INCORPORATED Discontinued 5MG Updated Report 2024-12-11 245270
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Discontinued 3MG Updated Report 2024-12-11 245273
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Discontinued 3MG Updated Report 2024-12-11 245276
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Discontinued 4.5MG Updated Report 2024-12-11 245279
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Discontinued 4.5MG Updated Report 2024-12-11 245282
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Discontinued 1.5MG Updated Report 2024-12-11 245285